<DOC>
	<DOC>NCT02060864</DOC>
	<brief_summary>In this trial, the effect of a low and a high dose AN-PEP will be investigated in gluten sensitive individuals. Volunteers receive a breakfast with background (0.5 g) gluten. Capsules are taken in the morning within 5 min after start of breakfast. Gastrointestinal fluid will be sampled over 3 hours to measure gluten degradation. After 5 volunteers have completed 3 test days, a blind interim analysis is performed by a third party based on which it is decided whether to proceed with the low AN-PEP dose.</brief_summary>
	<brief_title>Effect of AN-PEP Enzyme on Gluten Digestion in Gluten Sensitive Individuals</brief_title>
	<detailed_description />
	<criteria>Male/female Age â‰¥18 but &lt;70 yr Females: Hormonal contraceptive treatment Selfreported glutensensitive individuals fulfilling the Rome III criteria while consuming gluten Subject has read and understood the information provided on the study and given written informed consent Coeliac disease serology while consuming gluten (serological test for tissue transglutaminase IgA antibodies and total IgA antibodies) Wheat allergy (serological test for wheat protein IgE antibodies) Medication or medical condition that affects gastric emptying or secretion Females: Pregnancy or breastfeeding Inability to swallow the gastroduodenal feeding tube Any medical condition that in the opinion of the investigators may interfere with the study and may jeopardise the health status of the participant Any condition that in the opinion of the investigators may interfere with the study and may jeopardise the health status of the participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>enzyme</keyword>
	<keyword>gluten</keyword>
	<keyword>food intolerance</keyword>
</DOC>